Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Action inhibitors |
Mechanism TRIM24 inhibitors(Tripartite motif-containing protein 24 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC61H81N9O14S2 |
InChIKeyMZUVPSYPCGXWMF-JXZBIKIKSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
acute leukemia | Preclinical | United States | 05 Mar 2018 |